Comparison of Bioactive Compound Content in Carica papaya and Manihot esculenta Leaf Extract Based on FTIR (Fourier Transform Infrared) Analysis in Traditional Dengue Hemorrhagic Fever (DHF) Therapy
Abstract
Dengue Hemorrhagic Fever (DHF) is an infectious disease caused by the dengue virus transmitted by Aedes aegypti, often leading to thrombocytopenia. Herbal-based traditional therapies, such as papaya leaves (Carica papaya L.) and cassava leaves (Manihot esculenta Crantz), are considered potential supportive treatments. This study aims to compare the bioactive compounds of both plants through phytochemical screening and Fourier Transform Infrared (FTIR) analysis. The phytochemical results revealed that papaya leaves contain alkaloids, flavonoids, phenolics, tannins, saponins, steroids, and triterpenoids, while cassava leaves contain alkaloids, flavonoids, phenolics, tannins, and triterpenoids. FTIR analysis identified functional groups O–H, C=O, aromatic C=C, C–H, and C–O, indicating the presence of flavonoids, polyphenols, and glycosides. Pharmacologically, papaya leaf extract demonstrated greater potential as it has been clinically proven to increase platelet count through hematopoiesis stimulation and gene regulation. In contrast, cassava leaf extract exhibited antioxidant and hematopoietic potential but with limited clinical evidence. Therefore, papaya leaves are considered more effective as a traditional supportive therapy to aid
platelet recovery in DHF patients.
Copyright (c) 2025 Sistani Huzainiyah, Elsa Defitri, Funsu Andiarna, Eva Agustina, Risa Purnamasari, Nova Lusiana, Funsu Andirna, Irul Hidayat

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with us agree to the following terms:
- Authors retain copyright and grant the publisher right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this proceeding.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the proceeding's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this proceeding.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories, pre-prints sites or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater dissemination of published work




_page-00011.jpg)